XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information
Jun. 08, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 08, 2023
Entity Registrant Name Ovid Therapeutics Inc.
Entity Central Index Key 0001636651
Entity Emerging Growth Company false
Securities Act File Number 001-38085
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 46-5270895
Entity Address, Address Line One 441 Ninth Avenue
Entity Address, Address Line Two 14th Floor
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10001
City Area Code 646
Local Phone Number 661-7661
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol OVID
Security Exchange Name NASDAQ